Literature DB >> 3908543

Calmodulin in various insulin secreting cell types.

D Janjic, C B Wollheim, A E Renold.   

Abstract

The involvement of the Ca2+ binding protein, calmodulin, in the regulation of insulin release was studied. Calmodulin was measured in isolated rat islets, rat insulinoma cells, the insulin secreting cell line (RINm5F) and in islets isolated from normal and diabetic Chinese hamsters. Total content of calmodulin was determined by a radioimmunoassay using a rabbit anti-calmodulin serum and was found to lie in the range of 4 to 7 micrograms/ml protein. When rat islets were maintained in tissue culture for 6 days at 2.8 or 8.3 mM glucose, the content of calmodulin of the two groups was similar. Likewise there was no difference in calmodulin content between islets from normal and diabetic hamsters. This study suggests that a variation of the total cellular calmodulin does not play a role in the process of insulin secretion.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3908543     DOI: 10.1007/BF03348529

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  33 in total

1.  Ca2+-dependent regulator. Production and characterization of a monospecific antibody.

Authors:  J R Dedman; M J Welsh; A R Means
Journal:  J Biol Chem       Date:  1978-10-25       Impact factor: 5.157

2.  Stimulation of adenylate cyclase by Ca2+ and calmodulin in rat islets of langerhans: explanation for the glucose-induced increase in cyclic AMP levels.

Authors:  G W Sharp; D E Wiedenkeller; D Kaelin; E G Siegel; C B Wollheim
Journal:  Diabetes       Date:  1980-01       Impact factor: 9.461

3.  Coated charcoal immunoassay of insulin.

Authors:  V Herbert; K S Lau; C W Gottlieb; S J Bleicher
Journal:  J Clin Endocrinol Metab       Date:  1965-10       Impact factor: 5.958

4.  Sites of action of trifluoperazine in the inhibition of glucose-stimulated insulin release.

Authors:  D Janjic; C B Wollheim; E G Siegel; Y Krausz; G W Sharp
Journal:  Diabetes       Date:  1981-11       Impact factor: 9.461

Review 5.  Physiological implications of the presence, distribution, and regulation of calmodulin in eukaryotic cells.

Authors:  A R Means; J S Tash; J G Chafouleas
Journal:  Physiol Rev       Date:  1982-01       Impact factor: 37.312

6.  Calmodulin levels in diabetic mice.

Authors:  J E Morley; A S Levine; D M Brown; B S Handwerger
Journal:  Biochem Biophys Res Commun       Date:  1982-10-29       Impact factor: 3.575

7.  Insulin secretion by a transplantable rat islet cell tumour.

Authors:  A M Sopwith; J C Hutton; S P Naber; W L Chick; C N Hales
Journal:  Diabetologia       Date:  1981-09       Impact factor: 10.122

8.  Correlation of Ca2+-and calmodulin-dependent protein kinase activity with secretion of insulin from islets of Langerhans.

Authors:  J R Colca; C L Brooks; M Landt; M L McDaniel
Journal:  Biochem J       Date:  1983-06-15       Impact factor: 3.857

9.  Cyclic nucleotide phosphodiesterase of rat pancreatic islets. Effects of Ca2+, calmodulin and trifluoperazine.

Authors:  M C Sugden; S J Ashcroft
Journal:  Biochem J       Date:  1981-08-01       Impact factor: 3.857

10.  Calmodulin-binding proteins in a cloned rat insulinoma cell line.

Authors:  T Y Nelson; J M Oberwetter; J G Chafouleas; A E Boyd
Journal:  Diabetes       Date:  1983-12       Impact factor: 9.461

View more
  1 in total

1.  CGS 9343B and W7 (calmodulin antagonists) inhibit KCl-induced increase in cytosolic free calcium and insulin secretion of RINm5F cells.

Authors:  H Safayhi; M Kühn; I Koopmann; H P Ammon
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989 Jan-Feb       Impact factor: 3.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.